Form 8-K - Current report:
SEC Accession No. 0001274737-25-000055
Filing Date
2025-07-17
Accepted
2025-07-17 16:33:47
Documents
14
Period of Report
2025-07-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exdx-20250717.htm   iXBRL 8-K 34691
2 EX-10.1 directorcompensationprogra.htm EX-10.1 21668
3 EX-99.1 pressrelease-chasmckhann.htm EX-99.1 9691
  Complete submission text file 0001274737-25-000055.txt   190925

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exdx-20250717.xsd EX-101.SCH 1779
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exdx-20250717_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exdx-20250717_pre.xml EX-101.PRE 12506
16 EXTRACTED XBRL INSTANCE DOCUMENT exdx-20250717_htm.xml XML 2697
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Filer) CIK: 0001274737 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39049 | Film No.: 251131041
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)